Codon-Optimized Luciferase Variants for Mammalian Gene Expression in Culture and in Vivo

by Casey A. Maguire, Johannes C. van der Mijn, Marja H. Degeling, Danielle Morse, Bakhos A. Tannous
Published 2012-01-01

Irinotecan-Induced Dysarthria

by Albertine J. Dressel, Johannes C. van der Mijn, IJke J. Aalders, Rico N.P.M. Rinkel, Hans J. van der Vliet
Published 2012-01-01

Lactic Acidosis in Prostate Cancer: Consider the Warburg Effect

by Johannes C. van der Mijn, Mathijs J. Kuiper, Carl E.H. Siegert, Annabeth E. Wassenaar, Carel J.M. van Noesel, Aernout C. Ogilvie
Published 2017-11-01

Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma

by Johannes C. van der Mijn, Leiping Fu, Francesca Khani, Tuo Zhang, Ana M. Molina, Christopher E. Barbieri, Qiuying Chen, Steven S. Gross, Lorraine J. Gudas, David M. Nanus
Published 2020-02-01

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer

by Johannes C. van der Mijn, Nik Sol, Wouter Mellema, Connie R. Jimenez, Sander R. Piersma, Henk Dekker, Lisette M. Schutte, Egbert F. Smit, Henk J. Broxterman, Johan Skog, Bakhos A. Tannous, Thomas Wurdinger, Henk M. W. Verheul
Published 2014-12-01

Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection

by Costa Bachas, Jasmina Hodzic, Johannes C. van der Mijn, Chantal Stoepker, Henk M. W. Verheul, Rob M. F. Wolthuis, Emanuela Felley-Bosco, Wessel N. van Wieringen, Victor W. van Beusechem, Ruud H. Brakenhoff, Renée X. de Menezes
Published 2018-08-01

Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.

by Johannes C van der Mijn, Bashir Al Hussein Al Awamlh, Aleem Islam Khan, Lina Posada-Calderon, Clara Oromendia, Jonathan Fainberg, Mark Alshak, Rahmi Elahjji, Hudson Pierce, Benjamin Taylor, Lorraine J Gudas, David M Nanus, Ana M Molina, Joseph Del Pizzo, Douglas S Scherr
Published 2019-01-01

Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome

by Mariette Labots, Thang V. Pham, Richard J. Honeywell, Jaco C. Knol, Robin Beekhof, Richard de Goeij-de Haas, Henk Dekker, Maarten Neerincx, Sander R. Piersma, Johannes C. van der Mijn, Donald L. van der Peet, Martijn R. Meijerink, Godefridus J. Peters, Nicole C.T. van Grieken, Connie R. Jiménez, Henk M.W. Verheul
Published 2020-02-01